Search | Page 5 | Aplastic Anemia and MDS International Foundation

Search

Search results

  1. Taming the nausea, vomiting caused by chemo

    ... , according to results from a large NCI-funded phase III clinical trial . Patients in the trial were being treated with chemotherapy ...

    Article last updated 08/11/2016 - 3:27pm.

  2. Design and rationale of the QUAZAR Lower-Risk MDS (AZA-MDS-003) trial: a randomized phase 3 study of CC-486 (oral azacitidine) plus best supportive care vs placebo plus best supportive care in patients with IPSS lower-risk myelodysplastic syndromes and po

    ... modifier azacitidine . In an expanded phase 1 trial, CC-486 demonstrated clinical and biological activity in patients with International Prognostic ...

    Research Article last updated 06/23/2016 - 10:17am.

  3. Clinical Trial Basics

    Clinical trials offer hope for many people and an opportunity to help ... the future. If you are searching for a specific clinical trial , go to clinical trials search page .  What is a clinical ...

    Page last updated 01/20/2015 - 4:46pm.

  4. A Rare Case of Aplastic Anemia Later in Life Doesn’t Stop Al Meyer

    ... had no response to.  So in late 2013, they put me in a clinical trial for eltrombopag, which I had already tried once before, but this is ...

    Patient Chronicle last updated 07/12/2017 - 1:52pm.

  5. Major news in BMT with half-match donors

    ... and the primary investigator of many UT Southwestern clinical trials related to bone marrow transplantation. Mr. Dandridge enrolled in one such UT Southwestern clinical trial , studying a therapy called AG-221, developed by Agios Pharmaceuticals ...

    Article last updated 06/14/2016 - 3:02pm.

  6. Effect of lenalidomide treatment on clonal architecture of myelodysplastic syndromes without 5q deletion

    ... MDS patients randomized in the GFM-Len-Epo2008 clinical trial to lenalidomide or lenalidomide + EPO. Clonal evolution was analyzed ...

    Research Article last updated 04/29/2016 - 11:33am.

  7. CASCADE (SGN33A-005)

    For more details on this clinical trial, including contact information, please see this trial’s listing on ... the efficacy, appropriateness or suitability of any clinical trial listed on this website. Pharmaceutical company sponsored ...

    Clinical Trial last updated 06/19/2017 - 2:43pm.

  8. Study of Vadastuximab Talirine (SGN-CD33A; 33A) in Combination With Azacitidine in Patients With Previously Untreated Higher Risk MDS

    For more details on this clinical trial, including contact information, please see this trial’s listing on ... the efficacy, appropriateness or suitability of any clinical trial listed on this website. Pharmaceutical company sponsored ...

    Clinical Trial last updated 06/19/2017 - 2:44pm.

  9. Self-injected PNH therapy on the horizon

    ... positive interim data from the first cohort in its phase Ib trial that show maintenance of complement inhibition using Coversin in healthy ... diseases, and Alexion presented the first clinical data for its own next-generation complement inhibitors. Overall, we ...

    Article last updated 07/07/2016 - 9:40am.

  10. Personalized medicine for MDS

    ... in myelodysplastic syndromes: wishful thinking or already clinical reality? Original Publication Date:  ... approach, however, has not been tested in a clinical trial .  -One personalized approach for lower-risk patients with MDS is ...

    Research Review last updated 05/02/2016 - 9:44am.